Wenming Liu

Wenming Liu is a highly experienced finance professional specializing in financial planning and analysis within the biopharmaceutical and healthcare sectors. Currently serving as a Senior Director at Coherus BioSciences, responsibilities include overseeing budget and forecasting activities for commercial manufacturing and inventory related to biopharmaceutical products. Previous roles include Director of FP&A at Guardant Health, where support was provided to various operational teams and the cost accounting functions were managed. At Astellas Gene Therapies, Wenming Liu focused on technical operations and cost accounting related to gene therapy manufacturing. Experience also includes significant financial planning and operations roles at Orchard Therapeutics, Santen, Portola Pharmaceuticals, and Novartis. An educational background features an MBA from Rutgers University-Newark and advanced degrees in chemistry from the University of Illinois Chicago, Dalian Institute of Chemical Physics, and Nankai University.